Hims & Hers is a newfangled telehealth company that started to ride the waves of GLP-1 weight loss medications. As waves go, this one’s given the stock a heck of ride; way up and then all the ...
Hims & Hers is shutting down the dermatology business it acquired in 2021, BI has learned. It said it's closing the skincare site Apostrophe to centralize its teledermatology offerings. Hims ...
Telehealth personalized care company Hims & Hers shuttered a central part of its dermatology offering, skincare brand Apostrophe, to "simplify" its dermatology offerings and operations ...
Hosted on MSN1mon
Is Hims & Hers Health, Inc. (HIMS) Among the Best Beauty Stocks to Buy According to Hedge Funds?Beauty products sold by the company include face cleansers, moisturizers, lotions, and sunscreen. Hims & Hers Health, Inc. (NYSE:HIMS)’s business strategy is focused on recurring, subscription ...
Apostrophe, a skin care telehealth brand headquartered in the Bay Area, is shutting down after almost four years under the Hims & Hers corporate umbrella. The skin care company, founded in ...
Hims & Hers Health (HIMS) stock enjoyed a 10% jump in price last week on news that the company plans to continue offering compounded versions of Ozempic and Wegovy. This approach is in response to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback